Open questions — spinal stenosis¶
Last curated: 2026-08-30
Stable identifiers (OQ-n) persist if wording is sharpened. Tier 1 questions are practice-changing and designable now; Tier 2 questions require measurement maturation, larger infrastructure or mechanistic work. “Open” means the retrieved evidence does not resolve the stated causal or decision question—not that no related paper exists.
Tier 1 — would change practice; designable today¶
OQ-1 — Which clinical–imaging phenotype predicts extra benefit from lumbar decompression?¶
MRI severity poorly explained baseline disability in 437 NORDSTEN surgical candidates, while individual clinical findings have limited standalone diagnostic accuracy (Aaen 2022, PMID 34797405; Cook 2020, PMID 31312914). A prospective treatment-effect model should predefine symptom pattern, compartment/level, objective walking, neurological deficit and psychosocial/frailty variables, then validate externally against decompression versus structured rehabilitation.
OQ-2 — What is clinically meaningful lumbar instability that requires fusion?¶
The Swedish and NORDSTEN trials show no routine disability advantage from added fusion for many patients with stenosis and degenerative spondylolisthesis, but the smaller SLIP trial reported a more favorable fusion signal (Försth 2016, PMID 27074066; Austevoll 2021, PMID 34347953; Ghogawala 2016, PMID 27074067). A trial should enrich for prespecified dynamic translation, deformity, mechanical pain and facet-resection features and test interaction rather than subgroup outcome alone.
OQ-3 — Which exercise components and dose produce the walking benefit?¶
Thirteen exercise trials used 23 interventions and 60 components; cycling, strengthening, stretching and psychologically informed elements appeared more often in successful programs, but supervision and dose could not be resolved (Comer 2024, PMID 37715644). A factorial or sequential multiple-assignment trial with fidelity measurement could separate components.
OQ-4 — Does supervised multimodal rehabilitation delay surgery without sacrificing long-term function?¶
Short-term trials favor supervised or individualized multimodal care on several outcomes, while six-month group differences can diminish (Schneider 2019, PMID 30646197; Minetama 2019, PMID 30986577). A pragmatic trial needs standardized crossover rules, objective walking and cumulative surgery over at least two years.
OQ-5 — Is any lumbar epidural-injection subgroup steroid-responsive?¶
Glucocorticoid plus lidocaine provided no important average six-week advantage over lidocaine alone in 400 patients, and injection route did not identify benefit (Friedly 2014, PMID 24988555). A credible subgroup study must predefine inflammatory/radicular features and test treatment interaction against anesthetic and sham/no-injection strategies.
OQ-6 — Does percutaneous ligamentum-flavum decompression beat optimized rehabilitation and standard decompression on total burden?¶
MiDAS ENCORE compared MILD with epidural injection, while reviews identify comparator and selection limitations (Benyamin 2016, PMID 27228511; Yuan 2023, PMID 37954472). Needed outcomes include walking, complications, repeat procedures, recovery time and cost over ≥3 years.
OQ-7 — Do interspinous spacers reduce total harm or shift it into later reoperation?¶
Device trials show symptom improvement but frequently compare one spacer with another; in one five-year cohort, 75% were free from index-level reoperation/revision/fixation (Patel 2015, PMID 25494323; Nunley 2017, PMID 28919727). A decompression-controlled pragmatic trial should measure cumulative procedures and device-specific harm.
OQ-8 — Why do SPORT long-term comparisons diverge by enrollment cohort?¶
Four-year adjusted as-treated effects favored surgery, while at eight years the randomized cohort converged and the observational cohort retained advantage amid high crossover and roughly half retention (Weinstein 2010, PMID 20453723; Lurie 2015, PMID 25569524). Causal analyses should model preference, time-varying treatment, attrition and subsequent procedures together.
OQ-9 — Which mild DCM patients deteriorate enough to justify early surgery?¶
Meta-analysis estimates mild-DCM stability at 91% at one year and 75% at five years, with wide credible intervals; current guidance permits either surgery or supervised structured rehabilitation (Sarraj 2024, PMID 37549831; Fehlings 2017, PMID 29164035). A prospective surveillance cohort needs repeated dexterity, gait, examination, imaging and patient-derived outcomes.
OQ-10 — What monitoring interval is safe for nonmyelopathic cervical cord compression?¶
Guidance recommends education and clinical follow-up rather than prophylactic surgery when compression exists without myelopathy or radiculopathy, while radiculopathy raises progression risk (Fehlings 2017, PMID 29164035). In a live PubMed update on 2026-08-30, the retrieved monitoring review defined the need for a framework and better tools but did not establish a validated interval or minimum examination battery (Tetreault 2022, PMID 34971524).
OQ-11 — Does earlier DCM diagnosis improve recovery independent of baseline severity?¶
Primary-care reviews document delayed recognition and current guidance links trajectory and severity to management (Milligan 2019, PMID 31515310; Fehlings 2017, PMID 29164035). A health-system intervention can randomize diagnostic education/pathway support and measure time to specialist assessment, preoperative severity and postoperative recovery.
OQ-12 — Which cervical approach maximizes net benefit for multilevel DCM?¶
Anterior/posterior and laminoplasty/fusion meta-analyses show tradeoffs with major confounding by alignment and disease extent (Xu 2017, PMID 28687344; Zhao 2021, PMID 35111804). A registry-embedded trial should stratify alignment, compression direction, levels, frailty and baseline axial pain.
OQ-13 — Can surgery prevent falls and participation loss in DCM, not only improve mJOA?¶
Prospective before/after data show falls falling from 497.4 to 90.3 per 100 person-years and motor deterioration per fall from 34% to 8%, but no nonsurgical control was used (Kimura 2020, PMID 31809466). Controlled longitudinal work should include near-falls, fear, exposure and activity.
OQ-14 — Which frailty intervention changes spine-surgery outcomes?¶
Frailty predicts adverse degenerative-spine outcomes, but indices and optimization pathways vary (Chan 2021, PMID 33548521; Baek 2023, PMID 37996826). A trial should target modifiable domains and measure delirium, discharge home, function and treatment completion.
OQ-15 — Can a delirium-prevention bundle reduce the high actively detected rate in older spine patients?¶
Validated prospective surveillance found delirium in 40.5% of adults aged ≥70, with 47.2% of cases purely hypoactive (Brown 2016, PMID 27696373). A multicenter implementation trial should combine cognition, medication, pain, sleep, mobility and hydration components.
OQ-16 — What outcome set should determine lumbar treatment success?¶
ZCQ, ODI, self-paced walking, six-minute walk and daily steps measure distinct constructs, and responsiveness varies (Indrekvam 2024, PMID 39134699; Minetama 2019, PMID 30986577). Consensus should predefine a core set plus responder thresholds and cumulative procedures.
OQ-17 — Does patient co-produced information change DCM decisions or delay?¶
Interviews found wide variation in information provision, while patient-partnered work identified 68 consequences beyond conventional scales (Sangeorzan 2023, PMID 37205664; Davies 2022, PMID 33203262). A co-designed decision-support trial can measure knowledge, decisional conflict, delay and safety behavior.
Tier 2 — enabling science and infrastructure¶
OQ-18 — Can dynamic or weight-bearing imaging improve concordance?¶
Supine MRI does not reproduce every loading condition, and weight-bearing MRI can reveal dynamic stenosis/spondylolisthesis (Hansen 2019, PMID 31745952). The open question is incremental predictive value over symptoms, examination and standard imaging—not whether images look different.
OQ-19 — Can digital walking measures become treatment-effect markers?¶
Lumbar smart-shoe and wearable gait studies are exploratory, and DCM review found 12 tools with limited psychometric quality (Morimoto 2023, PMID 38162877; Choy 2022, PMID 35441108). Harmonized acquisition, meaningful-change thresholds and impact trials are required.
OQ-20 — Which cord-imaging measure predicts DCM recovery?¶
Conventional signal and emerging diffusion/brain measures correlate variably with disease and outcome (Soda 2022, PMID 36248151; Rajan 2022, PMID 36447347). External validation must show improvement beyond mJOA, duration and age.
OQ-21 — Are circulating proteins or microRNAs clinically incremental DCM biomarkers?¶
Prospective serum-protein, microRNA and proteomic studies report candidate signatures (Vedantam 2025, PMID 40215624; Divi 2024, PMID 38711175; Poulin 2026, PMID 41104894). The 2026-08-30 update found externally validated digital screening discrimination but not external validation of these fluid panels or a completed decision-impact study (Jin 2026, PMID 42448819).
OQ-22 — What biological process links chronic compression to variable cord vulnerability?¶
DCM pathophysiology includes mechanical injury, ischemia, blood–spinal-cord-barrier disruption and neuroinflammatory responses (Nouri 2015, PMID 25839387; Akter 2020, PMID 32425740). Human longitudinal studies must connect pathway markers to decline and decompression response.
OQ-23 — Does sarcopenia modify lumbar symptom trajectory or only reflect disability?¶
Paraspinal wasting and sarcopenia correlate with degenerative anatomy and alignment, but directionality and treatment interaction are uncertain (Schönnagel 2024, PMID 37788745; Liu 2024, PMID 39668686). Longitudinal muscle and activity measurements could separate cause, consequence and common aging.
OQ-24 — Can prediction models generalize across scanners, systems and treatment thresholds?¶
Automated MRI grading and AI prediction studies are proliferating, but definitions, labeling and external validation differ (Laulloo 2023, PMID 35762545; Rhee 2025, PMID 40152984). Calibration and clinical-impact studies are needed before workflow use.
OQ-25 — What is the global patient experience outside surgical high-income cohorts?¶
Retrieved qualitative work comes mainly from surgical or online samples in high-income settings (Knutsson 2022, PMID 35106129; Davies 2022, PMID 33203262). Multilingual community-based sampling should examine access, work, caregiving and financial burden.
OQ-26 — What outcomes matter to caregivers?¶
Patient-derived DCM work broadened outcomes but did not establish a caregiver core set (Davies 2022, PMID 33203262; Sangeorzan 2023, PMID 37205664). Caregiver time, safety supervision and recovery burden need direct study.
Dots not yet connected¶
Each row joins two evidence bodies present in this condition while identifying the absent junction study.
| # | Dot A | Dot B | The missing junction | Powers |
|---|---|---|---|---|
| D1 | Severe MRI grade poorly predicts baseline disability (PMID 34797405) | Objective walking responds to rehabilitation (PMID 30986577) | Test whether dynamic walking phenotype, not static grade, predicts rehabilitation vs decompression benefit | OQ-1, OQ-16 |
| D2 | Developmental stenosis predicts long-term lumbar deterioration (PMID 40939213) | Routine fusion adds no average benefit (PMID 27074066) | Determine whether developmental canal anatomy modifies decompression technique—not fusion by default | OQ-1, OQ-2 |
| D3 | Exercise programs rarely include balance (PMID 37715644) | DCM/lumbar patients are older and fall-vulnerable (PMID 33496544) | Add balance/fall endpoints to lumbar rehabilitation factorial trials | OQ-3, OQ-14 |
| D4 | Steroid adds little over lidocaine (PMID 24988555) | Digital mobility captures real-world walking (PMID 38162877) | Test whether injection produces a short-lived mobility signal invisible to pain scales | OQ-5, OQ-19 |
| D5 | Spacer cohorts show later reoperation (PMID 28919727) | Frailty predicts surgical harm (PMID 33548521) | Compare total device vs decompression burden stratified by frailty and life expectancy | OQ-7, OQ-14 |
| D6 | Fusion trials show similar average disability (PMID 39111800) | MRI/facet measures are common but symptom-discordant (PMID 34797405) | Prospectively validate instability features as treatment-effect modifiers | OQ-2 |
| D7 | Mild DCM has variable deterioration (PMID 37549831) | Wearable gait tools are emerging (PMID 35441108) | Test whether home gait change detects deterioration before mJOA decline | OQ-9, OQ-19 |
| D8 | DCM surgery reduces observed falls (PMID 31809466) | Patients report broad participation consequences (PMID 33203262) | Connect fall reduction to regained community activity and confidence | OQ-13, OQ-16 |
| D9 | Fluid biomarkers are emerging (PMID 40215624) | Symptom duration/severity shape surgical recovery (PMID 29164035) | Test incremental prognosis and treatment timing beyond clinical variables | OQ-20, OQ-21 |
| D10 | Information provision varies (PMID 37205664) | Clinician DCM knowledge is incomplete (PMID 31932384) | Randomize matched clinician education plus patient decision support | OQ-11, OQ-17 |
| D11 | Delirium is frequent and often hypoactive (PMID 27696373) | DCM surgery may reduce falls (PMID 31809466) | Measure whether perioperative delirium erodes the later mobility/fall benefit | OQ-13, OQ-15 |
| D12 | Paraspinal wasting correlates with LSS anatomy (PMID 37788745) | Supervised exercise improves walking responders (PMID 30986577) | Test whether muscle phenotype predicts or mediates rehabilitation response | OQ-3, OQ-23 |
| D13 | SPORT loses randomized-cohort advantage at 6–8 years (PMID 25569524) | Subsequent surgery rates are central in fusion trials (PMID 39111800) | Emulate a target trial with time-varying surgery and cumulative procedures | OQ-8 |
| D14 | Global access organizations document underserved spine care | Qualitative stenosis evidence is high-income and surgical (PMIDs: 35106129, 33203262) | Build multilingual community cohorts linked to objective function and care access | OQ-25 |
Questions retired or merged in this build¶
- Seed question “Which clinical–imaging pattern predicts decompression benefit?” → OQ-1.
- Seed question “What defines instability that truly requires fusion?” → OQ-2.
- Seed question “Which exercise components matter?” → OQ-3.
- Seed SPORT-convergence question → OQ-8.
- Seed wearable-walking question → OQ-19.
- Seed mild-DCM deterioration question → OQ-9.
- Seed minimally invasive device question → split into OQ-6 and OQ-7.